journal article·2026-06Open access

Stimuli-responsive metal-organic frameworks for inflammatory bowel disease: Integrating targeted therapy and molecular diagnosis

Yimeng Fang, Huaibiao Xu, Junying Qu, Zhou Yi, Xiaofei Hong, Haiying Wang, Jiaojiao Yang, Rongbing Chen, Hanbing Wang, Qinsi Yang, Jianshu Li, Wei Wu, Da Sun, Lilei Zhuang

Abstract

Metal-organic framework (MOF) materials provide a designable platform for precisely intervening in the complex microenvironment of inflammatory bowel disease (IBD). This review first systematically elaborates on the rational design strategies for Metal-organic frameworks (MOFs) targeting the pathological features of IBD (such as abnormal pH and reactive oxygen environment), covering the selection of particle size, active metal nodes and functional ligands. Secondly, it summarizes various therapeutic construction strategies of MOFs as drug carriers or by directly constructing the drugs as the framework itself. Furthermore, it provides a detailed review of the latest therapeutic applications and mechanisms of various stimulus-responsive MOFs in IBD animal models. At the same time, the article objectively points out the fundamental challenges that this technology faces before moving towards clinical application, including long-term biological safety, the feasibility of large-scale production, and the absence of the final product form. This review aims to provide comprehensive insights and references for the development of MOF-based precise diagnosis and treatment strategies for IBD through the above systematic elaboration. • MOFs enable targeted, pH-responsive drug release in inflamed gut tissue. • Bioactive MOFs deliver both structural and therapeutic functions in IBD. • Scalable synthesis yields biocompatible MOFs for clinical translation. • MOFs alleviate inflammation and oxidative stress in the colon. • Theranostic MOFs integrate drug delivery with inflammation detection.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Inflammatory Bowel Disease · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (94)

Show source-provided references
1. Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group, Global evolution of inflammatory bowel disease across epidemiologic stages10.1038/s41586-025-08940-0 ↗
2. Ulcerative colitis10.1038/s41572-020-0205-x ↗
3. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China, Lancet Gastroenterol
4. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 201710.1016/S2468-1253(19)30333-4 ↗
5. Multiomics to elucidate inflammatory bowel disease risk factors and pathways10.1038/s41575-022-00593-y ↗
6. Implications of the changing epidemiology of inflammatory bowel disease in a changing world10.1002/ueg2.12317 ↗
7. Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms10.1136/gutjnl-2024-332523 ↗
8. Kammermeier · Hepatol. · 2023 · 8 · 271
9. The gut microbiota and inflammatory bowel disease10.1007/s00281-014-0454-4 ↗
10. Colonic epithelial cell diversity in health and inflammatory bowel disease10.1038/s41586-019-0992-y ↗
11. Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteria10.1016/j.ebiom.2025.105721 ↗
12. Mechanisms of disease: inflammatory bowel diseases10.1016/j.mayocp.2018.09.013 ↗
13. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis10.1136/gutjnl-2014-306998 ↗
14. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis10.1016/S2468-1253(21)00014-5 ↗
15. Nanoparticles: emerging carriers for drug delivery10.1016/j.jsps.2011.04.001 ↗
16. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery10.1080/17425247.2021.1828339 ↗
17. Drug loading in chitosan-based nanoparticles10.3390/pharmaceutics16081043 ↗
18. Metal-Organic frameworks (MOFs)-Based nanomaterials for drug delivery10.3390/ma14133652 ↗
19. Recent advances in polymeric nanocomposites of metal-organic frameworks (MOFs)10.3390/polym11101627 ↗
20. Metal-organic frameworks for stimuli-responsive drug delivery10.1016/j.biomaterials.2019.119619 ↗
21. An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease
22. Metal‐Organic frameworks for the therapy of inflammatory diseases10.1002/adhm.202404334 ↗
23. Functionalized ZIF-8 as a versatile platform for drug delivery and cancer therapy: strategies, challenges and prospects10.1039/D4TB02289K ↗
24. Improving the drug delivery performance of ZIF-8 with amine functionalization as a 5-fluorouracil nanocarrier10.1038/s41598-025-03542-2 ↗
25. pH-responsive copper-doped ZIF-8 MOF nanoparticles for enhancing the delivery and translocation of pesticides in wheat plants10.1039/D3EN00300K ↗
26. Retrieving the stability and practical performance of activation-unstable mesoporous Zr(IV)-MOF for highly efficient self-calibrating acidity sensing10.1002/anie.202422517 ↗
27. Nanoceria as an electron reservoir: spontaneous deposition of metal nanoparticles on oxides and their anti-inflammatory activities10.1021/acsnano.2c07306 ↗
28. Nanozyme-mediated drug ion-exchange strategy ameliorates inflammatory bowel disease by scavenging ROS and reprogramming proinflammatory macrophages10.1016/j.cej.2025.170265 ↗
29. Trojan horse-inspired smart single-atom nanozyme delivery system for synergistic therapy of inflammatory bowel disease
30. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation
31. Toward sustainable tackling of biofouling implications and improved performance of TFC FO membranes modified by Ag-MOF nanorods10.1021/acsami.0c13029 ↗
32. Synthesis, characterization, and CO2 adsorption of three metal-organic frameworks (MOFs): MIL-53, MIL-96, and amino-MIL-5310.1016/j.poly.2016.06.034 ↗
33. In situ infrared spectroscopic and gravimetric characterisation of the solvent removal and dehydroxylation of the metal organic frameworks UiO-66 and UiO-6710.1007/s11244-013-0027-0 ↗
34. Optimization of washing processes in solvothermal synthesis of nickel-based MOF-7410.3390/ma13122741 ↗
35. Simplifying the synthesis of metal–organic frameworks10.1021/accountsmr.3c00121 ↗
36. Effects of acid modulators on the microwave-assisted synthesis of Cr/Sn metal-organic frameworks10.3390/polym14183826 ↗
37. Control of catenation in CuTATB-n metal–organic frameworks by sonochemical synthesis and its effect on CO2 adsorption10.1039/c0jm03318a ↗
38. Electrochemical synthesis of some archetypical Zn 2+ , Cu 2+ , and Al 3+ metal organic frameworks10.1021/cg300552w ↗
39. Metal-organic frameworks: drug delivery applications and future prospects
40. Curcumin encapsulated zeolitic imidazolate frameworks as stimuli responsive drug delivery system and their interaction with biomimetic environment10.1038/s41598-017-12786-6 ↗
41. “Clickable” ZIF-8 for cell-type-specific delivery of functional proteins10.1021/acschembio.1c00872 ↗
42. Caffeine encapsulation in metal organic framework MIL-53(Al) at pilot plant Scale for preparation of polyamide textile fibers with cosmetic properties10.1021/acsami.2c04293 ↗
43. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
44. Biofunctionalization of metal–organic framework nanoparticles via combined nitroxide-mediated polymerization and nitroxide exchange reaction10.1002/mame.202300048 ↗
45. Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy10.7150/thno.80687 ↗
46. Calcium coordination solids for ph-triggered release of olsalazine10.1002/cmdc.201700540 ↗
47. Antifungal‐Inbuilt Metal–Organic‐Frameworks eradicate Candida albicans biofilms10.1002/adfm.202000537 ↗
48. A chlorin-based Nanoscale metal-organic framework for photodynamic therapy of Colon cancers10.1021/jacs.5b04069 ↗
49. Tumor targeted porphyrin-based metal–organic framework for photodynamic and checkpoint blockade immunotherapy10.1016/j.colsurfb.2024.113965 ↗
50. Evolution of nMOFs in photodynamic therapy: from porphyrins to chlorins and bacteriochlorins for better efficacy10.3389/fphar.2025.1533040 ↗
51. The emerging role of oxidative stress in inflammatory bowel disease10.3389/fendo.2024.1390351 ↗
52. Metal-organic frameworks (MOFs) for phototherapy and synergistic phototherapy of cancer10.1016/j.ccr.2024.216381 ↗
53. Zinc-Based metal-organic frameworks in drug delivery, cell imaging, and sensing10.3390/molecules27010100 ↗
54. Metal–organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives10.1186/s12951-025-03252-x ↗
55. pH-Responsive metal–organic framework thin film for drug delivery10.1021/acs.langmuir.2c02497 ↗
56. Controlled release of small molecules and proteins from DNA-surfactant stabilized metal organic frameworks10.1039/D0TB00767F ↗
57. Advancing stroke therapy: the potential of MOF-based nanozymes in biomedical applications
58. Inflammatory targeted nanoplatform incorporated with antioxidative nano iron oxide to attenuate ulcerative colitis progression10.1016/j.isci.2025.112448 ↗
59. Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications10.1039/D1CS00918D ↗
60. Pushing the limits on the intestinal crossing of metal–organic frameworks: an Ex Vivo and In Vivo detailed Study10.1021/acsnano.1c10942 ↗
61. Olsalazine-Based metal–organic frameworks as biocompatible platforms for H 2 adsorption and drug delivery10.1021/jacs.6b03523 ↗
62. Efficient oral delivery of resveratrol-loaded cyclodextrin-metal organic framework for alleviation of ulcerative colitis10.1016/j.ijpharm.2023.123496 ↗
63. Orally administered metal–organic framework nanocubes for sequence-targeted quercetin delivery in colitis alleviation10.1016/j.cej.2025.160373 ↗
64. Montmorillonite-Enveloped zeolitic imidazolate framework as a nourishing oral nano-platform for gastrointestinal drug delivery10.1021/acsami.0c15494 ↗
65. Biomineralized ZIF-8 encapsulating SOD from hydrogenobacter thermophilus: maintaining activity in the intestine and alleviating intestinal oxidative stress10.1002/smll.202402812 ↗
66. Hydrogel–metal-organic-framework hybrids mediated efficient oral delivery of siRNA for the treatment of ulcerative colitis10.1186/s12951-022-01603-6 ↗
67. Regulation of inflammatory macrophages by oral mineralized metal-organic framework nanoparticles for the synergistic treatment of ulcerative colitis and liver injury10.1016/j.cej.2023.143655 ↗
68. Metal–Organic‐Framework‐Based hydrogen‐release platform for multieffective Helicobacter Pylori targeting therapy and intestinal flora protective capabilities
69. Biomimetic MOF nanoparticles delivery of C-Dot nanozyme and CRISPR/Cas9 System for site-specific treatment of ulcerative colitis10.1021/acsami.1c21700 ↗
70. An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment10.1016/j.jconrel.2025.114411 ↗
71. Recent advances in MOF-based nanozymes: synthesis, activities, and bioapplications10.1016/j.bios.2024.116593 ↗
72. Ligand‐Dependent activity engineering of glutathione peroxidase‐mimicking MIL‐47(V) metal–organic framework nanozyme for therapy10.1002/anie.202010714 ↗
73. Microfluidic encapsulated manganese organic frameworks as enzyme mimetics for inflammatory bowel disease treatment10.1016/j.jcis.2021.09.016 ↗
74. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy10.1126/sciadv.abb2695 ↗
75. Curcumin-Encapsulated Co-ZIF-8 for ulcerative colitis therapy: ROS scavenging and macrophage modulation effects10.1021/acsomega.4c02446 ↗
76. Ti-Based nanoMOF as an efficient oral therapeutic agent10.1021/acsami.9b06472 ↗
77. Nanometric MIL-125-NH2 metal-organic framework as a potential nerve agent antidote carrier10.3390/nano7100321 ↗
78. Metal-Organic frameworks and their composites towards biomedical applications10.3389/fmolb.2021.805228 ↗
79. Superoxide dismutase-embedded metal–organic frameworks via biomimetic mineralization for the treatment of inflammatory bowel disease10.1039/D2TB00896C ↗
80. Mesopore to macropore transformation of metal–organic framework for drug delivery in inflammatory bowel disease10.1002/adhm.202000973 ↗
81. Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease10.1016/j.carbpol.2022.119252 ↗
82. Orally administrable H2S-Scavenging metal–organic framework prepared by Co-Flow microfluidics for comprehensive restoration of intestinal milieu
83. Near-Infrared fluorescence MOF nanoprobe for adenosine triphosphate-guided imaging in colitis10.1021/acsami.0c13003 ↗
84. Orally administrable H2 S-Scavenging metal-organic framework prepared by Co-Flow microfluidics for comprehensive restoration of intestinal milieu
85. Recent advances in continuous flow synthesis of metal–organic frameworks and their composites10.1039/D4CC02088J ↗
86. Mitigating metal-organic framework (MOF) toxicity for biomedical applications10.1016/j.cej.2023.144400 ↗
87. Development of the design and synthesis of metal–organic frameworks (MOFs) – from large scale attempts, functional oriented modifications, to artificial intelligence (AI) predictions10.1039/D4CS00432A ↗
88. An intelligent prediction model for the synthesis conditions of metal–organic frameworks utilizing artificial neural networks enhanced by genetic Algorithm optimization10.1021/acs.jcim.4c00997 ↗
89. Structure-Based drug design with geometric Deep Learning: a Comprehensive Survey
90. Advances and prospects in Alzheimer's disease diagnosis and treatment using MOFs and COFs: mechanism and AI-assisted strategies10.1016/j.reactfunctpolym.2025.106601 ↗
91. Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
92. Nanoscale MOFs: from synthesis to drug delivery and theranostics applications10.1016/j.addr.2022.114496 ↗
93. Tumor diagnosis and therapy system based on covalent organic framework (COF): from sensing detection to synergistic treatment10.1016/j.colsurfb.2026.115541 ↗
94. Photodynamic therapy for inflammatory and cancerous diseases of the intestines: molecular mechanisms and prospects for application10.7150/ijbs.87492 ↗